Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Smoldering Multiple Myeloma

This nonrandomized clinical trial examines the safety, tolerability, immunogenicity, and anti–multiple myeloma activity of the PVX-410 multipeptide vaccine with or without lenalidomide.

https://ift.tt/2OCnNDZ